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Abstract
Background: The flower bud of Syzygium aromaticum (L.) Merr. & Perry. (clove) has been used in
Unani medicine since ancient times for the treatment of male sexual disorders. The present study
is aimed to investigate the effect of 50% ethanolic extract of clove on general mating behaviour,
libido, potency along with its likely gastric ulceration and adverse effects on sexually normal male
albino rats.
Methods: The suspension of the extract was administered orally at the dose of 100, 250, and 500
mg / kg, to different groups of male rats (n = 6) once a day for seven days. The female albino rats
involved in mating were made receptive by hormonal treatment. The general mating behaviour,
libido and potency were determined and compared with the standard reference drug sildenafil
citrate. The probable gastric ulceration and adverse effects of the extract were also evaluated.
Results: Oral administration of the extract significantly increased the Mounting Frequency,
Intromission Frequency; Intromission Latency, Erections; Quick Flips, Long Flips as well as
aggregate of penile reflexes and caused significant reduction in the Mounting Latency and Post
Ejaculatory Interval. The most appreciable effect of the extract was observed at the dose of 500
mg/kg. The test drug was also found to be devoid of any conspicuous gastric ulceration and adverse
effects.
Conclusion: The results indicated that the 50% ethanolic extract of clove produced a significant
and sustained increase in the sexual activity of normal male rats, without any conspicuous gastric
ulceration and adverse effects. Thus, the resultant aphrodisiac effectivity of the extract lends
support to the claims for its traditional usage in sexual disorders.
Background
Clove is the dried flower bud of Syzygium aromaticum (L.)
Merr. & Perry. (Family: Myrtaceae) an evergreen tree 10–
20 m in height indigenous to India, Indonesia, Zanzibar,
Mauritius and Sri Lanka [1]. It is one of the most impor-
tant drugs used in indigenous medicine in India, espe-
cially in Unani medicine. Clove is reported as aphrodisiac
[2], stomachic [3,4], carminative, antispasmodic [5,6]. It
is reported to be useful in conceiving in high doses and act
as a contraceptive in low doses [7] and useful in cataract
[8]. Clove is also reported to have anticarcinogenic prop-
erty [9]. It inhibits platelet aggregation and alters
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posseses antiviral activity against Herpes simplex [11]. Phy-
tochemical studies indicate that the clove contains free
eugenol, eugenol acetate, caryophyllene, sesquetrepene
ester [12], phenyl propanoid [13], β caryophyllene [14],
eugenol and acetyle eugenol [15]. Eugenol, the major con-
stituent, inhibits lipid peroxidation and maintains activi-
ties of enzyme superoxide dismutase, catalase,
glutathione peroxidase-6 phosphate dehydrogenase [16],
and has also been reported to have vasodilatory [17] and
smooth muscle relaxant property [18]. Phyto chemical
study of the test drug that was carried out according to the
methods described by Jenkin et al [19], showed that it
contains alkaloids, amino acids, flavonoids, proteins, ster-
ols, reducing sugar, tannins and phenols. However, clove,
or its known compound had not been scientifically stud-
ied for their effect on sexual function. Earlier we carried
out a preliminary study of hydro alcoholic extract (50%)
of clove using only mounting frequency and mating per-
formance as the marker for sexual function in normal
male mice, and the results from our study demonstrated
the aphrodisiac activity and safety from short term toxicity
of the test drug [20].
The present study thus, is aimed to investigate the aphro-
disiac effect of 50% ethanolic extract of clove in detail,
using multiple parameters along with its probable gastric
ulceration and adverse effects in sexually normal male
albino rats. The doses used in the study were selected
according to the Freirich [21], multiplying the Unani clin-
ical doses reported in standard Unani text [2] by the con-
version factor of 7.
Methods
Plant material and extraction
The authenticated dried flower bud of S. aromaticum
(clove) was procured from the market (Delhi, India). A
voucher (S721) sample was kept for further reference. The
clove was crushed to coarse powder and sieved through
No. 20 mesh size. The extraction was carried out by mix-
ing the powdered clove with 1:3 w/v in 50% ethanol v/v
by Soxhlet apparatus for 6 h. The extract was filtered and
the solvent from the filtrate was removed by rotary evap-
orator under reduced pressure and low temperature. The
yield of extract was 10.40% w/w in terms of dried starting
material. It was yellowish and of pleasant smell. The
extract was preserved in a refrigerator.
Chemicals used
Sildenafil citrate was purchased from Zydus Cadila,
(Ahmadabad, India). Other drugs used were ethinyl
oestradiol (Infar Limited, Calcutta, India), progesterone
(Sun Pharmaceutical Industries Limited, Mumbai, India)
and 5% xylocane ointment (Astra IDL Limited, Bangalore,
India)
Animals
Twelve weeks old male and female albino rats of wistar
strain weighing 350–400 g and 225–275 g respectively,
were used for the study. They were housed singly in sepa-
rate standard cages and maintained under standard labo-
ratory conditions (temperature 24–28°C, relative
humidity 60–70%, 12 h light-dark cycle) with free access
to solid pellet diet (Gold Mohar, Lipton-India) and water
ad libitum throughout the study except during the experi-
ment. The study design was approved by the ethical com-
mittee of the Department for animal care and use.
Drug preparation
Since clove in Unani medicine is orally administered,
therefore, the extract of clove was suspended in distilled
water using Tween 80 (1%) for oral administration. Silde-
nafil citrate and ethinyl oestradiol were also suspended in
distilled water using Tween 80 (1%) separately, for oral
use. Progesterone was dissolved in olive oil for subcutane-
ous injection. All the drug solutions were prepared just
before administration.
Mating behaviour test
The test was carried out by the methods of Dewsbury and
Davis Jr [22] and Szechtman et al [23], modified by Amin
et al [24]. Healthy and sexually experienced male albino
rats (350–400 g) that were showing brisk sexual activity
were selected for the study. They were divided into 5
groups of 6 animals each and kept singly in separate cages
during the experiment. Group 1 represented the control
group, which received 10 ml/kg of distilled water orally.
Groups 2–4 received suspension of the extract of clove
orally at the doses of 100, 250 and 500 mg/kg, respec-
tively, daily for 7 days at 18:00 h. Group 5 served as stand-
ard and given suspension of sildenafil citrate orally at the
dose of 5 mg/kg, 1 h prior to the commencement of the
experiment. Since the male animals should not be tested
in unfamiliar circumstances the animals were brought to
the laboratory and exposed to dim light (in 1 w fluores-
cent tube in a laboratory of 14' × 14') at the stipulated
time of testing daily for 6 days before the experiment.
The female animals were artificially brought into oestrus
(heat) [25] by the Szechtman et al method (as the female
rats allow mating only during the estrus phase) They were
administered suspension of ethinyl oestradiol orally at
the dose of 100 µg/animal 48 h prior to the pairing plus
progesterone injected subcutaneously, at the dose of 1
mg/animal 6 h before the experiment. The receptivity of
the female animals was confirmed before the test by
exposing them to male animals, other than the control,
test and standard animals. The most receptive females
were selected for the study. The experiment was carried
out on the 7th day after commencement of the treatment
of the male animals. The experiment was conducted atPage 2 of 7
(page number not for citation purposes)
BMC Complementary and Alternative Medicine 2004, 4:17 http://www.biomedcentral.com/1472-6882/4/1720:00 h in the same laboratory and under the light of
same intensity. The receptive female animals were intro-
duced into the cages of male animals with 1 female to 1
male. The observation for mating behaviour was immedi-
ately commenced and continued for first 2 mating series.
The test was terminated if the male failed to evince sexual
interest. If the female did not show receptivity she was
replaced by another artificially warmed female. The occur-
rence of events and phases of mating were called out to be
recorded on audio-cassette as soon as they appeared. Their
disappearance was also called out and recorded. Later, the
frequencies and phases were determined from cassette
transcriptions: number of mounts before ejaculation or
Mounting Frequency (MF), number of intromission
before ejaculation or Intromission Frequency (IF), time
from the introduction of female into the cage of the male
upto the first mount or Mounting Latency (ML), time
from the introduction of the female up to the first
intromission by the male or Intromission Latency (IL),
time from the first intromission of a series upto the ejacu-
lation or Ejaculatory Latency (EL), and time from the first
ejaculation upto the next intromission by the male or Post
Ejaculatory Interval (PEI). In the second mating series
only the EL was recorded. The values for the observed
parameters of the control, test and standard animals were
statistically analysed by using one-way analysis of vari-
ance (ANOVA) method.
Test for libido
The test was carried out by the method of Davidson [26],
modified by Amin et al [24]. Sexually experienced male
albino rats were divided into 5 groups of 6 animals each
and kept singly in separate cages during the experiment.
Group 1 represented the control group, which received 10
ml/kg of distilled water orally. Groups 2–4 received sus-
pension of the extract orally at the doses of 100, 250 and
500 mg/kg, respectively, once a day in the evening (18:00
h) for 7 days. Group 5 served as standard and given sus-
pension of sildenafil citrate orally at the dose of 5 mg/kg,
1 h prior to the commencement of the experiment. The
female rats were made receptive by hormonal treatment
and all the animals were accustomed to the testing condi-
tion as previously mentioned in mating behaviour test.
The animals were observed for the Mounting Frequency
(MF) on the evening of 7th day at 20:00 h. The penis was
exposed by retracting the sheath and 5% xylocaine oint-
ment was applied 30, 15 and 5 min before starting obser-
vations. Each animal was placed individually in a cage
and the receptive female rat was placed in the same cage.
The number of mountings was noted. The animals were
also observed for intromission and ejaculation. The MF in
control, test and standard animals was statistically ana-
lysed by employing one-way analysis of variance
(ANOVA) method.
Test for potency
The effect of the test drug was studied according to the
methods described by Hart and Haugen [27] and Hart
[28], modified by Amin et al [24]. The male animals were
divided into 5 groups of 6 animals each and kept singly in
separate cages during the experiment. Group 1 repre-
sented the control group, which received 10 ml/kg of dis-
tilled water orally. Groups 2–4 received suspension of the
test drug orally at the doses of 100, 250 and 500 mg/kg,
respectively, daily for 7 days. Group 5 received a suspen-
sion of sildenafil citrate orally at the dose of 5 mg/kg, 1 h
before the commencement of the experiment. On the 8th
day, the test for penile reflexes was carried out by placing
the animal on its back in a glass cylinder partial restraint.
The preputial sheath was pushed behind the glans by
means of thumb and index finger and held in this manner
for a period of 15 min. Such stimulation elicits a cluster of
genital reflexes. The following components were
recorded: Erections (E), Quick Flips (QF), and Long Flips
(LF). The frequency of these parameters observed in con-
trol, test and standard groups was statistically analysed by
using one-way analysis of variance (ANOVA) method.
Test for ulcerogenecity
The male animals (350–400 g) were divided into 4 groups
of 6 animals each. Group 1 represented the control group,
which received 10 ml/kg of distilled water. Groups 2–3
received suspension of the extract orally at the doses of
100, 250 and 500 mg/kg, respectively, daily for 7 days.
After the treatment, on 8th day all the animals were killed
and the stomach was then incised along the greater curva-
ture and washed carefully with physiological saline. Any
gastric lesions were observed immediately using a magni-
fying glass. The number of erosions per stomach was
assessed for severity, according to the score of Cioli et al
[29] : (o) absence of lesion, vasodilation or up to 3 pin
point ulcers; (1) more than 3 pin point ulcers, (2) from 1
to 5 small ulcers (< 2 mm); (3) more than 5 small ulcers
(< 2 mm), (4) 1 or more giant ulcers. Evaluation of gastric
damage was carried out by two observers, who followed
the same evaluation criteria.
Adverse effects
All treated rats were observed at least once daily for any
overt sign of toxicity (salivation, rhinorrhoea, lachryma-
tion, ptosis, writhing, convulsions and tremors), stress
(erection of fur and exophalmia) and changes in behav-
iour (such as spontaneous movement in the cage, climb-
ing, cleaning of face). In addition food and water intake
were noted.
Statistical analysis
The significance of difference between the means was
determined by one-way analysis of variance (ANOVA)Page 3 of 7
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significant.
Results
The data obtained with the mating behaviour test indi-
cated that the clove-extract at the dose of 500 mg/kg
increased the Mounting Frequency (MF) (P < 0.0001),
Intromission Frequency (IF) (P < 0.001) ; Ejaculatory
latency in first series (EL1) (P < 0.0001) and decreased
Mounting Latency (ML) (P < 0.0001), Intromission
Latency (IL) (P < 0.01) in a significant manner. The dose
250 mg / kg of the extract significantly increased the MF (P
< 0.001), IF (P < 0.05) and significantly reduced the ML (P
< 0.001), EL1 (P < 0.05); Post Ejaculatory Interval (PEI) (P
< 0.001) and did not significantly alter the IL (P < 0.61),
Ejaculatory Latency in second series (EL2) (P < 0.41).
Whereas the dose of the test drug at 100 mg/kg signifi-
cantly increased the MF (P < 0.05), PEI (P < 0.05) but did
not significantly affect the IF (P < 0.61), ML (P < 0.61), IL
(P < 0.61); EL1 (P < 0.61); EL2 (P < 0.81). However, the
standard drug increased the MF (P < 0.0001), IF (P <
0.0001); EL1 (P < 0.0001), EL2 (P < 0.0001); PEI (P <
0.0001) as well as decreased ML ((P < 0.0001) and IL (P <
0.0001) in a highly significant manner (Table 1).
The test for libido showed that the extract at the dose of
500 mg/kg increased the Mounting Frequency (MF) in a
significant manner (P < 0.001). The extract at the doses of
100 mg/kg and 250 mg/kg did not significantly alter the
MF(P < 0.24, P < 0.75 respectively). The standard drug
strikingly increased the MF (P < 0.0001). Intromission
and Ejaculation were found absent in control, test and
standard groups (Table 2).
The test for potency exhibited that the higher dose (500
mg/kg) of the test drug significantly increased the fre-
quency of Erections (E) (P < 0.0001), Quick Flips (QF) (P
< 0.0001), Long Flips (LF) (P < 0.0001) as well as the
aggregate of these penile reflexes (TPR) (P < 0.0001). The
extract at the dose of 250 mg/kg significantly increased the
E (P < 0.01), LF (P < 0.05) and TPR (P < 0.05) but com-
paratively less than the higher dose of the extract and
standard drug, and did not significantly increase the QF (P
< 0.10). whereas, the test drug at the dose of 100 mg/kg
did not alter the E (P < 0.78), QF (P < 0.78); LF (P < 0.44)
and TPR (P < 0.44) in a significant manner (Table 3).
Seven days treatment of low and high doses of the extract
caused no significant ulceration in gastric mucosa of
albino rats. Moreover, there were neither treatment
related defects nor overt clinical signs of toxicity, stress or
Table 1: Effect of 50% ethanolic extract of clove (S. aromaticum) on mating behaviour in male rats
Mean Frequency ± SEM
Parameters Control (10 ml/kg) Clove (100 mg/kg) Clove (250 mg/kg) Clove (500 mg/kg) Sildenafil citrate (5 mg/kg)
Mounting Frequency (MF) 11.50 ± 1.22 13.20 ± 1.47* 19.00 ± 1.10*** 31.80 ± 2.32**** 48.70 ± 2.34****
Intromission Frequency (IF) 5.50 ± 1.22 5.83 ± 1.17 NS 6.67 ± 0.81* 8.17 ± 1.47*** 24.70 ± 0.81****
Mounting Latency (ML, in sec) 35.30 ± 1.51 36.70 ± 1.21 NS 31.30 ± 1.63*** 24.30 ± 1.63**** 11.70 ± 1.37****
Intromission Latency (IL, in sec) 40.00 ± 5.29 41.30 ± 3.89 NS 38.50 ± 3.89 NS 21.00 ± 3.83** 15.00 ± 0.89****
Ejaculatory Latency in first series (EL1, in sec) 198.00 ± 0.98 201.00 ± 13.00 NS 208.00 ± 13.70* 233.50 ± 12.00**** 344.50 ± 12.00****
Ejaculatory Latency in second series (EL2, in sec) 297.33 ± 8.10 295.50 ± 11.70 NS 311.33 ± 9.67 NS 343.16 ± 7.70**** 398.16 ± 13.50****
Post Ejaculatory Interval (PEI, in sec) 364.00 ± 12.22 343.16 ± 7.70* 309.33 ± 10.90**** 217.33 ± 8.96**** 99.00 ± 5.68****
Tabular values are mean ± SEM, n = 6 (number of animals in each group); significant difference from control, NS: Not significant. * P < 0.05, ** P < 0.01; *** P < 0.001, **** P 
< 0.0001.
Table 2: Effect of 50% ethanolic extract of clove (S. aromaticum) on Mounting Frequency (test for libido) in male rats
Mean Frequency ± SEM
Parameters Control (10 ml/kg) Clove (100 mg/kg) Clove (250 mg/kg) Clove (500 mg/kg) Sildenafil citrate (5 mg/kg)
Mounting Frequency (MF) 6.17 ± 0.98 6.33 ± 0.81NS 7.17 ± 1.72 NS 11.20 ± 1.17* 23.00 ± 2.17**
Intromission Frequency (IF) Nil Nil Nil Nil Nil
Ejaculation (EJ) Absent Absent Absent Absent Absent
Tabular values are mean ± SEM, n = 6 n (number of animals in each group); significant difference from control, NS: Not significant. *P < 0.001,** P < 
0.0001Page 4 of 7
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and water intake of all test drug treated rats remained sim-
ilar to those of the control group.
Discussion
In the present study, clove (S. aromaticum) was tested in
animal experimentation for its effect on sexual behaviour,
and sildenafil citrate was used as the standard referent.
The study showed that the 50% ethanolic extract of clove
possesses significant sexual function enhancing activity as
observed in sexual behaviour tests. Mating behaviour test
revealed that the test drug significantly increased the
Mounting Frequency (MF) and Intromission Frequency
(IF) as compared to control but less than that of the stand-
ard drug. The (MF) and (IF) are considered as the indices
of both libido and potency. So, this is an indication that
the test drug possesses a sexual function improving effect.
The premature ejaculation is one of the important causes
of sexual dysfunction, so the assessment of Ejaculatory
Latency in first series (EL1) and in second series (EL2) was
studied. The test drug significantly increased the EL1 and
EL2 as compared to control animals, whereas a highly sig-
nificant increase was observed with the standard drug.
The test drug was found to produce a significant reduction
in the Mounting Latency (ML) and Intromission Latency
(IL) as compared to control while a highly significant
decrease was found in ML of animals treated with sildena-
fil citrate. This is also an evidence of the sexual function
improving effect of the clove.
The Post Ejaculatory Interval (PEI) is considered as an
index of potency and libido, and also a parameter of the
rate of recovery from exhaustion after first series of mat-
ing. PEI was found significantly decreased with clove-
extract and also with the standard drug. The test drug
decreased PEI either by enhancing the potency and libido
or by producing lesser exhaustion in the first series of mat-
ing or by both.
The effect of the test drug on libido was also evaluated by
testing the MF after genital anaesthetization which does
away with the reinforcing effect of genital sensation thus
affording the study of pure libido or intrinsic sexual
desire. During the experiment the extract produced a sig-
nificant increase in the MF of sexually normal male rats
whereas the efficacy of the standard drug, as expected, was
found to be highly significant. The MF was much reduced
in control, test and standard animals in comparison with
the MF of corresponding groups in mating behaviour test
where the penis had not been anaesthetized. None of the
control, test and standard animals were observed to show
Intromission or Ejaculation because their occurrence
depends upon local genital sensation which was
obstructed due to anaesthetization.
The effect on potency was also evaluated by testing the
effect of the drug on the frequency of penile reflexes
namely Erections (E), Quick Flips (QF), and Long Flips
(LF). The test drug significantly increased the frequency of
all the components of penile reflexes (E, QF, & LF) in the
test animals as compared to control group but compara-
tively lesser than the standard drug. The aggregate of
penile reflexes (TPR) was also found increased in the ani-
mals treated with the extract and sildenafil citrate. There-
fore, the experiment revealed that the test drug produced
a marked increase in potency.
The spices are reported to produce an increase in gastric
acid secretion by a cholinergic mechanism [30], and so,
their use for sexual invigoration may cause gastric ulcera-
tion and other adverse effects. Therefore, ulcerogenic and
other adverse effects of the extract were also evaluated. The
results of this evaluation were negative. This suggests that
the short term use of clove for this purpose is apparently
safe.
The results of the present study clearly proved that the
clove is endowed with sexual function improving activity.
This is in consonance with our earlier study showing sex-
ual function improving effect of the test drug in male
Table 3: Effect of 50% ethanolic extract of clove (S. aromaticum) on Penile reflexes (test for potency)
Mean Frequency ± SEM
Parameters Control (10 ml/kg) Clove (100 mg/kg) Clove (250 mg/kg) Clove (500 mg/kg) Sildenafil citrate (5 mg/kg)
Erections (E) 7.67 ± 1.63 8.33 ± 1.21 NS 10.50 ± 1.76** 13.80 ± 0.98*** 19.00 ± 2.64***
Quick Flips (QF) 5.17 ± 0.75 5.33 ± 1.21 NS 6.00 ± 1.22 NS 9.67 ± 1.37*** 17.30 ± 4.13***
Long Flips (LF) 2.17 ± 1.17 3.17 ± 1.50 NS 4.00 ± 1.55* 7.50 ± 1.22*** 12.00 ± 2.26***
Total Penile Reflexes (TPR) 15.01 ± 3.55 16.83 ± 7.21 NS 20.50 ± 4.53* 30.97 ± 3.50*** 48.30 ± 9.03***
Tabular values are mean ± SEM, n = 6 (number of animals in each group); significant difference from control, NS: Not significant. * P < 0.05, ** P < 
0.01; *** P < 0.0001.Page 5 of 7
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exhibited, as expected, tremendous activity. With regard
to the mechanism of the test drug, it is difficult to inter-
prete the mechanism involved in potentiation of sexual
function. The drugs induced changes in neurotransmitter
levels or their action at cellular levels could change sexual
behaviour [31]. Hence, the increased sexual function
could be due to the nervous stimulant action of the test
drug [32]. Further, phyto chemical study of the extract
indicated that it contains sterols and phenol. Thus, the
resultant aphrodisiac effectivity of the test drug might also
be attributed to sterols or phenolic compounds.
Moreover, research should be aimed at isolating the active
principle(s) responsible for aphrodisiac activity and the
mechanism by which the drug enhances sexual function.
In addition, to discover the applied effective concentra-
tion or dosages of the extract, more studies are also
required.
Conclusions
The present results indicated that the 50% ethanolic
extract of clove possesses potent aphrodisiac activity in
normal male albino rats without any gastric ulceration
and adverse effects and provided scientific evidence in
favour of the claims made in Unani medicine that the
clove is clinically useful as sexual invigorator in males.
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